Dr. Trauner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5855 Olivas Park Dr
Ventura, CA 93003Phone+1 805-667-2801
Summary
- Dr. Michael Trauner is a dermatologist in Ventura, CA. He received his medical degree from Duke University School of Medicine and has been in practice 20 years. He specializes in cosmetic dermatology and dermatologic surgery and is experienced in dermatologic surgery, cosmetic dermatology, and Mohs micrographic surgery.
Education & Training
- University of California Davis HealthResidency, Dermatology, 1997 - 2000
- Kaiser Permanente Northern California (Santa Clara)Internship, Internal Medicine, 1994 - 1995
- Duke University School of MedicineClass of 1994
Certifications & Licensure
- CA State Medical License 1995 - 2025
- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FAAD) American Academy of Dermatology
- Fellow (FASDS) American Society for Dermatologic Surgery
Clinical Trials
- Norursodeoxycholic Acid in the Treatment of Primary Sclerosing Cholangitis Start of enrollment: 2012 Dec 01
- Unravelling Mechanisms of Fructose vs Glucose Consumption in the Pathogenesis and Progression of NAFLD Start of enrollment: 2013 May 01
- norUrsodeoxycholic Acid vs Placebo in PSC Start of enrollment: 2018 Feb 08
Publications & Presentations
PubMed
- 28 citationsIndications for liver transplantation in adults : Recommendations of the Austrian Society for Gastroenterology and Hepatology (ÖGGH) in cooperation with the Austrian S...Ivo Graziadei, Heinz Zoller, Peter Fickert, Stefan Schneeberger, Armin Finkenstedt
Wiener Klinische Wochenschrift. 2016-09-02 - 320 citationsPatient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing CholangitisTobias J. Weismüller, Palak J. Trivedi, Annika Bergquist, Mohamad Imam, Henrike Lenzen
Gastroenterology. 2017-06-01 - 27 citationsChallenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH.Stefan Traussnigg, Christian Kienbacher, Emina Halilbasic, Christian Rechling, Lili Kazemi-Shirazi
Digestive Diseases. 2015-01-01
Press Mentions
- Time to Screen for Liver Disease in Type 2 Diabetes?October 5th, 2020
- NUDCA Analog Shows Promise in NAFLDJuly 29th, 2019
- Gilead Announces Positive Phase 2 Results for GS-9674 in Primary Sclerosing Cholangitis (PSC) at the Liver MeetingNovember 9th, 2018
- Join now to see all
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: